Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2023-09-06 Call Transcript
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details an investor relations event held on September 6, 2023, specifically a "业绩说明会" or "Performance Explanation Meeting" related to the 2023 half-year report. The content includes Q&A about the company's half-year financial performance, product development, market outlook, and strategies. The document is relatively short (2835 characters) and focuses on the discussion and explanation of the interim results rather than presenting full financial statements or detailed financial data. It is essentially a transcript or summary of an earnings presentation or performance briefing to investors. This fits the definition of a Call Transcript (CT) or an Investor Presentation (IP). However, since it is a record of an investor relations activity specifically called a "业绩说明会" (performance explanation meeting) and includes Q&A, it aligns best with a Call Transcript (CT) rather than a formal presentation document. Therefore, the most appropriate classification is Call Transcript (CT).
2023-09-06 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details an investor relations event held on September 6, 2023, specifically a "业绩说明会" or "performance explanation meeting" related to the company's 2023 half-year report. The content includes Q&A about the half-year financial performance, product development, market outlook, and company strategies. The document is relatively short (2835 characters) and focuses on the discussion and explanation of the interim results rather than presenting full financial statements or detailed financial data. It is essentially a transcript or summary of an earnings presentation session rather than the official interim report itself. Therefore, it fits best as a Call Transcript (CT) or an Investor Presentation (IP). However, since it is a record of an investor relations activity specifically described as a "performance explanation meeting" with Q&A, it aligns most closely with a Call Transcript (CT) category, which covers full text transcripts of company conference calls or earnings calls with Q&A. Confidence is high given the detailed Q&A format and the nature of the event.
2023-09-06 Chinese
2023 年半年度报告业绩说明会预告公告
Investor Presentation Classification · 90% confidence The document is a short announcement (1043 characters) about a scheduled performance explanation meeting related to the company's 2023 half-year report. It references the half-year report already published on August 28, 2023, and invites investors to participate in a webcast on September 6, 2023. The document does not contain actual financial data or detailed financial statements but serves as a notice for an upcoming earnings explanation event. According to the rules, such announcements about meetings or presentations related to financial results are classified as Investor Presentation (IP) if they provide detailed presentation content, or as Report Publication Announcement (RPA) if they announce the release of a report. However, this document is specifically about an earnings explanation meeting (业绩说明会), which is a type of earnings release presentation. Given the short length and nature of the document, it is best classified as an Investor Presentation (IP) announcement rather than the full report or earnings release itself.
2023-08-29 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金存放与实际使用情况的专项报告" which translates to a "Special Report on the Deposit and Actual Use of Raised Funds." It details the issuance of shares, the amount of funds raised, the usage of these funds, and compliance with regulatory requirements. It includes specific financial figures related to the capital raised and its deployment, as well as bank account balances for the raised funds. The document is focused on the management and use of capital raised through a public offering, which aligns with updates on company fundraising and capital structure changes. The document length is 3157 characters, which is relatively short but contains substantive financial data about capital usage, not just an announcement or a certification. Therefore, it is best classified as a Capital/Financing Update (CAP).
2023-08-27 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告摘要" which translates to "Half-Year Report Summary" or "Interim Report Summary" for the year 2023. It contains detailed financial data such as total assets, net profit, earnings per share, and other financial metrics for the reporting period and comparisons to the previous year. It also includes business descriptions, shareholder information, and notes on asset pledges and restrictions. The document explicitly states it is an unaudited half-year report summary and references the full half-year report for more details. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. The document length (4805 characters) is sufficient to contain actual financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. H1 2023
2023-08-27 Chinese
第三届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shanxi Dayu Bioengineering Co., Ltd. It details the meeting date, attendance, and the approval of two proposals: the 2023 semi-annual report and a special report on the use of raised funds. The document references the actual semi-annual report and the special report as being published separately on the Beijing Stock Exchange information disclosure platform with specific announcement numbers. The document itself does not contain the financial data or the full report but is a formal announcement of the meeting resolutions approving these reports. The document length is short (1025 characters), and it serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as the semi-annual report (IR) or a report publication announcement (RPA) since it contains substantive meeting details and voting results rather than just a notice of publication.
2023-08-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.